Johnson & Johnson’s blood cancer medicine cleared for bi-weekly use
HQ Team February 21, 2024: Johnson & Johnson announced that USFDA had approved a bi-weekly dose of its blood cancer therapy Tecvayli. The regulatory.
Drugs
Health
Pharma
Drugs
Health
Pharma
EMA recommends stopping sale of GSK’s blood cancer drug in EU
The European Medicines Agency has recommended the stoppage of conditional marketing authorisation for GSK’s Blenrep (belantamab mafodotin), a medicine used to treat cancer of.
Drugs
Health
Pharma
US regulator approves Pfizer’s Elrexfio to treat multiple myeloma
HQ Team August 15, 2023: The USFDA has granted accelerated approval for Pfizer Inc’s Elrexfio to treat incurable blood cancer, multiple myeloma, that.
Drugs
Health
Pharma
USFDA green lights Janssen’s Talvey to treat multiple myeloma
HQ Team August 11, 2023: The USFDA has granted accelerated approval to Janssen Pharmaceutical Companies for its cancer antibody treatment, Talvey, to treat.
Drugs
Pharma
US court dismisses antitrust claims against Dr. Reddy’s cancer drug
A US court dismissed all claims against Dr. Reddy's Laboratories Inc., a wholly-owned subsidiary, in an antitrust complaint related to the cancer drug.
Drugs
Pharma
J&J gets FDA approval for therapy to treat blood cancer
J &J gets approval from FDA for medicine to treat a type of blood cancer-Multiple Myeloma